Asthma

ACCP Asthma

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/60221

Contents of this Issue

Navigation

Page 11 of 11

Asthma Exacerbations Figure 1. Management of Asthma Exacerbations: Emergency Department and Hospital-Based Care Initial Assessment > History and physical exam (auscultation, accessory muscle use, heart and respiratory rate) > FEV1 > O2 or PEFR (vs. personal best or predicted if personal best unknown) > Other tests as indicated saturation FEV1 or PEFR ≥ 40% (Mild-to-Moderate) > Oxygen to achieve SaO2 > Inhaled SABA by nebulizer or MDI with valved holding chamber, up to 3 doses in first hour ≥ 90% > Oral systemic corticosteroids if no immediate response or if patient recently took oral systemic corticosteroids FEV1 or PEFR < 40% (Severe) > Oxygen to achieve SaO2 > High-dose inhaled SABA plus ipratropium by nebulizer or MDI plus valved holding chamber, every 20 minutes or continuously for 1 hour Repeat Assessment (symptoms, physical exam, PEFR, O2 Moderate Exacerbation > FEV1 or PEFR 40-69% > Physical exam; moderate symptoms > Inhaled SABA q60min > Oral systemic corticosteroid > Continue treatment 1-3 hr provided there is improvement, make admit decision in ≤ 4 h predicted/personal best Good Response > FEV1 ≥ 90% Impending/Actual Respiratory Arrest > Intubation and mechanical ventilation with 100% O2 > Nebulized SABA and ipratropium > Oral systemic corticosteroids saturation, other tests as needed) Severe Exacerbation > FEV1 > Physical exam: severe symptoms at rest, accessory muscle use, chest retractions or PEFR < 40% predicted/personal best > History: high risk > No improvement after initial treatment: ▶ Oxygen ▶ Nebulized SABA + ipratropium, hourly or continuously ▶ Oral systemic corticosteroid ▶ Consider adjunct therapies > Response sustained 60 min after last treatment or PEFR ≥ 70% > No distress > Physical exam normal Discharge Home > Continue with SABA > Continue oral systemic corticosteroid Incomplete Response > FEV1 > Mild to moderate symptoms or PEFR 40-69% Individualize decision regarding hospitalization > Patient education: ▶ Review medication use and inhaler technique ▶ Review/initiate action plan ▶ Recommend close medical follow-up Admit to Hospital Ward > Inhaled SABA > Systemic corticosteroid (oral or IV) Admit to Hospital ICU (Table 9) > O2 > Monitor vital signs, FEV1 or PEFR, SaO2 Improved Poor Response > FEV1 > PCO2 > Intravenous corticosteroid > Consider adjunct therapies > Symptoms severe, drowsiness, confusion or PEFR < 40% ≥ 42 mm Hg > O2 > Inhaled SABA hourly or continuously > IV corticosteroid > Possible intubation and mechanical ventilation Improved

Articles in this issue

Archives of this issue

view archives of Asthma - ACCP Asthma